Tokyo, Jan. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060313) titled 'Clinical results of zoledronic acid in the treatment of osteoporosis' on Jan. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Niimi orthopaedics clinic
Condition:
Condition - Osteoporosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the treatment outcomes of twice-weekly injections of zoledronic acid in real-world clinical practice.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 30
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Osteoporosis
Key exclusion criteria - Patients who are contraindicated or require cautio
Patients who are currently pregnant, breastfeeding, or wish to become pregnant
Individuals who cannot provide consent for research
Target Size - 700
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2018 Year 01 Month 01 Day
Date of IRB - 2025 Year 12 Month 01 Day
Anticipated trial start date - 2018 Year 08 Month 01 Day
Last follow-up date - 2035 Year 12 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068995
Disclaimer: Curated by HT Syndication.
